Targeting ROS1 rearrangements in non-small cell lung cancer with crizotinib and other kinase inhibitors.

ABSTRACT:

SUBMITTER: Sehgal K 

PROVIDER: S-EPMC6186457 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature